Nuvectis Pharma, Inc. 10-Q

Item 5. Other Information. N o n e . ​ 22 ​ Item 6. Exhibits ​ ​ Exhibit No. Description ​ ​ ​ ​ ​ ​ 31.1* ​ Certification of Chief Executive Officer of Nuvectis Pharma, Inc. pursuant to Rule 13a-14(a)/15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, dated May 7, 2024. 31.2* ​ Certification of Principal Financial Officer of Nuvectis Pharma, Inc. pursuant to Rule 13a-14(a)/15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, dated May 7, 2024. 32.1** ​ Certification of Chief Executive Officer of Nuvectis Pharma, Inc. pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, dated May 7, 2024. 32.2** ​ Certification of Principal Financial Officer of Nuvectis Pharma, Inc. pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, dated May 7, 2024. 101* ​ The following financial information from the Company’s quarterly report on Form 10-Q for the period ended March 31, 2024, formatted in Inline Extensible Business Reporting Language (XBRL): (i) the Condensed Balance Sheets, (ii) the Condensed Statements of Operations, (iii) the Condensed Statement of Shareholders’ Equity, (iv) the Condensed Statements of Cash Flows, and (v) Notes to the Condensed Financial Statements. 104* ​ Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101). ​ * Filed herewith. ** Furnished herewith. ​ ​ ​ 23 ​ Signatures Pursuant to the requirements of the Securities Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Fort Lee, State of New Jersey, on this 7 th day of May 2024. Nuvectis Pharma, Inc. By: /s/ Ron Bentsur Name: Ron Bentsur Title: Chairman, Chief Executive Officer and President ​ ​ ​ ​ ​ By: /s/ Michael J Carson ​ Name: Michael J Carson ​ Title: Vice President of Finance (Principal Financial and Accounting Officer) ​ ​ ​ 24